Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

NF 023, Tocris Bioscience™

Catalog No. p-4785221 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Selective and competitive P2X1 antagonist

A subtype-selective, competitive and reversible P2X1 receptor antagonist. Displays IC50 values of 0.21, 28.9, > 50 and > 100 μM for human P2X1, P2X3, P2X2, and P2X4-mediated responses respectively. Selective over adrenoceptors, histamine and P2Y receptors. Also selectively inhibits the α-subunit of Go/i (EC50 ∽300 nM). Also inhibits DNA-binding activity of HMGA2 (IC50 = 10.63 μM).

Chemical Identifiers

CAS 104869-31-0
Molecular Formula C35H20N4Na6O21S6
Molecular Weight (g/mol) 1162.851
InChI Key FMQURVHYTBGYSQ-UHFFFAOYSA-H
Synonym 8,8'-[carbonylbis(imino-3,1-phenylenecarbonylimino)]bis-1,3,5-naphthalene-trisulphonic acid, hexasodium salt
PubChem CID 101921976
IUPAC Name hexasodium;3-[[N-[3-[N-(4,8-disulfo-6-sulfonatonaphthalen-1-yl)-C-oxidocarbonimidoyl]phenyl]-C-oxidocarbonimidoyl]amino]-N-(8-sulfo-4,6-disulfonatonaphthalen-1-yl)benzenecarboximidate
SMILES C1=CC(=CC(=C1)NC(=NC2=CC=CC(=C2)C(=NC3=C4C(=CC(=CC4=C(C=C3)S(=O)(=O)O)S(=O)(=O)[O-])S(=O)(=O)O)[O-])[O-])C(=NC5=C6C(=CC(=CC6=C(C=C5)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]

Specifications

Quantity 10 mg
Formula Weight 1162.86
Percent Purity >98%
Chemical Name or Material NF 023
Recommended Storage Desiccate at Room Temperature
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.